PROVIDENCE, R.I. [Brown University] The gene editing technique CRISPR has been making headlines worldwide for its potential to change the genetic makeup of organisms and treat genetic diseases such as sickle cell anemia. It has vast potential in many areas including neuroscience.
Neuroscientists are currently using this technique to unravel how the brain works and hope to one day adapt it to offer treatments and cures for various neurological disorders, with certain forms of blindness perhaps most imminent, said Kate OConnor-Giles, Provosts Associate Professor of Brain Science at Brown University. The possibilities for neuroscience are wide open.
CRISPR allows researchers to precisely cut and alter the DNA of a cell. Using CRISPR, scientists can probe the genes that underlie nervous system function in model organisms by introducing mutations, including those associated with disease. This allows scientists to study the effects of changes in genes on nervous system development, function and behavior.
Kate O'Connor-Giles is a Brown associate professor of brain science who uses CRISPR in her research.CRISPR consists of two components: Cas9, an enzyme that cuts DNA and is often referred to as molecular scissors, and a synthetic RNA molecule called a gRNA, which can be programmed to recognize specific sites in the genome.
You can target Cas9 pretty much anywhere in the genome where it will then cleave DNA, said OConnor-Giles, who is affiliated with Browns Carney Institute for Brain Science. This then opens a window of opportunity for re-coding the DNA by hijacking the cells DNA repair machinery. This allows us to do all sorts of things, such as deleting one or more genes or introducing different kinds of mutations.
OConnor-Giles discussed how she and her team have been using the CRISPR technique, as well as what neuroscientists like her hope to do in the future, ahead of an April 27 Carney Conversations event where shell further explore the potential of gene editing technology in neuroscience.
Many of the genes that regulate nervous system development, function and maintenance are poorly understood. Changing this is one of the major areas of research in our lab. With it becoming easier to determine what genetic changes lead to atypical neurodevelopment, many uncharacterized genes are being linked to neurological disorders. CRISPR allows us to rapidly generate animal models to study how these genes function in an intact nervous system.
Similarly, CRISPR can be used for studying gene mutations in human cells. Neurons can be induced from stem cells with the altered gene, as well as from stem cells in which the disease-causing change has been repaired by CRISPR. This allows neuroscientists to study the effect of disease-associated genetic changes in the exact genetic background of the person to understand how that change is impairing the nervous system in the specific context of that persons neurons. This is important because we all have slightly different genomes with small changes sprinkled throughout that may alter the effect of a disease-associated change.
In combination, animal and stem cell models generated with CRISPR technology are powerful tools for understanding neurological disorders. We can use CRISPR to study the effect of differences in genes on brain aging. We can also use CRISPR in model organisms to identify new genes that play important roles in the nervous system. The more of this we achieve, the more likely it is that when a change in a gene is found to underlie a neurological disorder in a patient, well already have an understanding of what that gene does and what treatment options may be available, or promising avenues for investigation.
In 2012, my lab wanted to use gene editing to study new genes we had identified as candidate regulators of communication in the brain. We started by working to improve methods for gene editing in flies, which back then was time-consuming and often not even possible.
We were following any developments in gene editing closely, and we started paying attention to CRISPR as soon as the Doudna and Charpentier labs showed that it could be used to edit DNA in a tube. When multiple labs showed in January and February 2013 that CRISPR could work in cells, it was instantly clear that this approach was as simple as the first step in gene editing cutting DNA at a specific site was going to get. So, we decided to immediately focus our efforts on adapting CRISPR in flies and formed a collaboration with the labs of Jill Wildonger and Melissa Harrison. We had our first evidence that CRISPR was working in flies by April 2013, and we published the results the following month. This gave us the ability to essentially edit genes at will in flies, and we prioritized the open distribution of our reagents and approaches to make sure this was true for the entire fly community. It was a pretty exciting time, and Im thrilled to have been part of it. The impact has been long-lasting, with CRISPR completely revolutionizing our ability to study neuronal genes in the lab.
CRISPR greatly expands our ability to study disease mechanisms in model organisms and stem cells so that we can understand why neurological function is negatively affected. This foundational research is currently the area where CRISPR has the greatest impact. In our lab, for example, were using CRISPR to study genes whose loss has been linked to intellectual disability but have not been studied in the context of the brain. While there is also potential to use CRISPR to cure neurological disease, this needs to be balanced against the risks associated with breaking DNA. The delivery of CRISPR components to cells in the brain also presents a challenge. For this reason, retinal disorders involving more accessible neurons in the eye are currently the most promising candidates for CRISPR-based treatments in the nervous system.
I think there are three primary concerns when considering manipulating human genomes. First, safety can we use CRISPR in a way that doesnt risk introducing mutations? Breaking DNA is inherently risky. The cell wont necessarily repair the break as planned, and we could break DNA at unintended sites in the genome, accidentally introducing new mutations that could disrupt the function of other genes and result in different deleterious effects depending on the affected gene or genes.
Second, efficacy can we actually conduct CRISPR in humans with high enough efficiency to be useful in the treatment of disease? As I mentioned, a major bottleneck here is the delivery of CRISPR components to the relevant cells. This is especially true in the human nervous system with its billions of neurons.
And third, there are ethical concerns, for example, surrounding equitable access to CRISPR-based therapies and the use of CRISPR to make changes to genomes that go beyond correcting disease-associated changes. This is a critical issue that extends well beyond the science, and should involve all of us thinking hard about how we do and do not want to use gene editing in humans. This is one of the main reasons its so important that we all have a basic understanding of CRISPR, what it can and cant do, and how this may change in the relatively near future.
The precision and efficacy of CRISPR are improving steadily. And new CRISPR systems with distinct properties such as targeting RNA instead of DNA are being identified all the time. Scientists are also constantly devising new applications, such as using base editors, which enable gene editing without the risky introduction of DNA breaks, or adapting RNA-cleaving forms of CRISPR for detecting viruses or bacteria. CRISPR is evolving rapidly on numerous fronts, and I fully expect well see many advances in the coming years.
Follow this link:
How Brown neuroscientists are using CRISPR to accelerate brain research and more - Brown University
- 100 plus years of stem cell research20 years of ISSCR - PMC - March 26th, 2024
- Stem Cell Science and Human Research Studies Ahead of Cargo Arrival - NASA Blogs - February 18th, 2024
- Stem cell research project to launch into space - Fox Weather - January 24th, 2024
- Breakthrough in cancer research opening up stem cell therapy to more people. How you can get involved - 69News WFMZ-TV - January 20th, 2024
- Stem Cell Research Heading to the ISS on Axiom Mission 3 - ISS National Lab - January 18th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - The Dispatch - January 12th, 2024
- Applications are open for the Maryland Stem Cell Research Fund - Technical.ly - January 4th, 2024
- Global Stem Cell Therapy Market to Reach USD 928.6 Million by 2031: Says Allied Market Research - Yahoo Finance - November 19th, 2023
- Current state of stem cell-based therapies: an overview - PMC - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance Regenrative Medicine - Yahoo Finance - November 3rd, 2023
- Research Fellow (Aging and Cancer Stem Cell Laboratory ... - Times Higher Education - October 15th, 2023
- Qkine Collaborates with the Cambridge Stem Cell Institute to Facilitate Same-Day Access to Key Research Products for Researchers at the Cambridge... - September 27th, 2023
- Stem cells: a comprehensive review of origins and emerging clinical ... - September 25th, 2023
- Stem Cell Research and Communicating Science | GBH - GBH News - September 20th, 2023
- Stem cell research reveals the earliest stages of a human life - SBS News - September 10th, 2023
- Stem Cell Therapy Market Size 2023 | Innovative Research Methodologies with Emerging Trends and Opportuni - Benzinga - September 10th, 2023
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research, Current Trends, Key Industry Play - Benzinga - September 8th, 2023
- Stem Cell Therapy Market 2023 Business Statistics and Research ... - The Knox Student - August 28th, 2023
- Autologous Stem Cell Based Therapies Market Analysis, Research ... - Chatfield News-Record - July 19th, 2023
- Global Stem Cell Market Projected to Reach $14 Bn by 2028: Ken Research - Yahoo Finance - July 11th, 2023
- Theradaptive Awarded Manufacturing Assistance Grant by the Maryland Stem Cell Research Fund - Benzinga - July 10th, 2023
- Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual... - June 19th, 2023
- Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023... - June 17th, 2023
- Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023: Effective Research Programs Hold Key in Roll Out of Advanced iPSC Treatments - Yahoo... - June 17th, 2023
- Lung and heart stem cell research paves way for new COVID-19 treatments - Medical Xpress - June 14th, 2023
- Toxicology PhD student cultivating giant leaps in stem cell research ... - June 4th, 2023
- Harvard Stem Cell Institute (HSCI) - May 26th, 2023
- Findings may lead to improved insulin-secreting cells derived from stem ... - May 26th, 2023
- Cell Press: Stem Cell Reports - May 26th, 2023
- Stem cell research could enable blood to be made in other parts of the body - Medical Xpress - May 26th, 2023
- Construction of myocardial patch with mesenchymal stem cells and poly ... - May 22nd, 2023
- Cedars-Sinai to Send Stem Cells to the Space Station to Aid in the ... - May 22nd, 2023
- researchers expand human blood stem cells | Institute for Stem Cell ... - May 22nd, 2023
- A Look Inside Stem Cells Helps Create Personalized Regenerative ... - May 17th, 2023
- Exclusive Research Report on Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market to Witness Comp - openPR - May 17th, 2023
- The Future of Stem Cell Research: Master of Science in ... - The Daily | Case Western Reserve University - May 10th, 2023
- Exclusive Research Report on Stem Cell Therapy for Diabetes and ... - Digital Journal - May 9th, 2023
- Aging melanocyte stem cells and gray hair | National Institutes of ... - May 5th, 2023
- Mouse hair turns gray when certain stem cells get stuck - May 5th, 2023
- Science-First Skincare Company Michal Morrison Secures Exclusive World-Wide License of Proprietary STEM6 Molecule, Supported by Over 25 Years of... - May 5th, 2023
- BioCentriq and panCELLa execute research agreement to study stem cell-derived Natural Killer cell expansi - Benzinga - May 3rd, 2023
- Hair turning gray? Study finds a stem cell 'glitch' may be the cause - May 1st, 2023
- Elevai Labs Announces Research Grant Award and Partnership to Better Characterize the 'Payload' of ELEVAI's Stem Cell-derived Exosomes - Yahoo Finance - April 27th, 2023
- Why does hair turn gray? A new study says 'stuck' stem cells may ... - NPR - April 27th, 2023
- Study advances understanding of how melanocyte stem cells work to color ... - April 21st, 2023
- Stem cell research and therapy legislation to be replaced, says ... - Bahamas Tribune - April 21st, 2023
- Stem Cell Research (journal) - Wikipedia - April 21st, 2023
- Scientists Are About to Try to Create Stem Cells in Space - April 21st, 2023
- Stem Cell Research & Therapy | Articles - BioMed Central - April 16th, 2023
- Stem Cell Junk Yards Reveal a New Clue About Aging | WIRED - April 16th, 2023
- Global Stem Cells Market Research Report 2023: Implications - April 16th, 2023
- Stem cell research can help people with hard- | EurekAlert! - April 16th, 2023
- University Of Edinburgh's stem cell research gets funding boost - India Education Diary - April 14th, 2023
- Two major stem cell research projects supported with more than ... - University of California, Santa Cruz - April 8th, 2023
- Cancer detection predicts tumors before they form: discovery - March 29th, 2023
- Stem cell therapy: a potential cure for hearing loss? - March 29th, 2023
- Turkey's Only Stem Cell Production Application and Research Center - Expat Guide Turkey - March 24th, 2023
- Stem Cell Research Article, Embryonic Cells Information, Cell Therapy ... - March 24th, 2023
- Scientists create mice with cells from 2 males for 1st time - March 19th, 2023
- QBRI concludes stem cells symposium - Gulf Times - March 17th, 2023
- 2020 California Proposition 14 - Wikipedia - March 17th, 2023
- Stem Cell Reports | Journal | ScienceDirect.com by Elsevier - March 17th, 2023
- Stem cell therapy MSC-NP found to ease inflammatory activity of brain ... - March 12th, 2023
- Stem Cell Research | Office of Research Compliance | SIU - March 12th, 2023
- Heart disease study shows hope for stem cell treatment - March 4th, 2023
- Stem cells drive antler regeneration | Science - March 4th, 2023
- Stem Cell Research: Argumentative Essay - Free Essay Example - Edubirdie - March 4th, 2023
- Stem Cell Research | Thermo Fisher Scientific - US - March 4th, 2023
- Stem cell controversy - Wikipedia - February 28th, 2023
- National Institutes of Health grant funds interdisciplinary ... - February 27th, 2023
- Research Associate in Cancer Stem Cell Research job with ... - Times Higher Education - February 25th, 2023
- Pioneering Stem Cell Research Conference at The Aga Khan ... - The Aga Khan University - February 25th, 2023
- Scientists grapple with ethics of stem cell research - STAT - February 17th, 2023
- Research Associate in Stem Cell Neurobiology job with KINGS ... - Times Higher Education - January 30th, 2023
- Stem cells: past, present, and future | Stem Cell Research & Therapy ... - January 12th, 2023
- Edu Thesis & Essay: Stem cell research outline top writers online! - January 12th, 2023
- Stem Cell Biology Research Program | Johns Hopkins Institute for Cell ... - January 5th, 2023
- Stem cell population identified is vital for bone regeneration: Research - ThePrint - January 5th, 2023
- Leading scientist 'blown away' by UAE advances in stem cell research - The National - December 15th, 2022
- The Stem Cell Assay Market Is Set To Grow At A 20% Annual Rate, Due To The High Prevalence Of Chronic Diseases As Per The Business Research Company's... - December 13th, 2022
Recent Comments